About ImQuest Pharma Therapeutic Focus Product Pipeline Scientific Staff News & Notes Investor Relation Contact Us Careers
  
 
Therapeutic Focus
General Information
Infectious Disease
Cancer
Topical Microbicides
Immune Modulation and
Inflammation
News and Notes
April 4th 2008:
ImQuest scientists present important HIV Microbicide results at Microbicides 2008 in Delhi, India.
   
April 1st 2008:
ImQuest publishes results of structure activity relationship study with pyrimidinedione HIV inhibitors.
   
September 24th 2007:
ImQuest Life Sciences announces the appointment of Robert Schooley, M.D. to its Scientific Advisory Board.
   
September 21st 2007:
ImQuest Life Sciences announces the appointment of David Ho, M.D. to its Scientific Advisory Board.
   
September 20th 2007:
ImQuest Life Sciences announces the appointment of Richard J. Whitley, M.D. as Chairman of its Scientific Advisory Board.
   
April 25th 2007:
ImQuest Life Sciences Receives Grant from International Partnership
for Microbicides to Develop Novel Microbicide
   
April 25th 2006:
ImQuest Life Sciences Licenses Piperazine Series of Anti-Cancer Therapeutic
Compounds from Samjin Pharmaceutical Co.
   
 News Archieve
Welcome to ImQuest Life Sciences Welcome to ImQuest Life Sciences
 
Events
The XVI International AIDS Conference will be held in Toronto, Canada from August 13-18, 2006.
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) will be held in San Francisco California from September 27-30, 2006.
DART-HIV will be held in Cancun Mexico from December 10-14, 2006.
International Conference on Antiviral Research will be held in Palm Springs California from April 29-May3, 2007.

 
Press Resources
For more information on ImQuest Life Sciences, please contact:

For corporate information, including information for investors, please contact:

Jerry Cartright, Chief Executive Officer
Phone: 301-696-0274
rbuckheit@imquest.com
 
For technical product information on ImQuest scientific programs, please contact:

Robert W. Buckheit, Jr., Ph.D. President and Chief Scientific Officer
Phone: 301-696-0274
Fax: 301-696-0381
rbuckheit@imquest.com
 
Infectious Disease
IQP-0410 for  HIV
HBV Lead Discovery
Anti-Cancer Agents
IQP-0303 for
leukemia
IQP-0304 for prostate
cancer
Topical Microbicides
IQP-0528
IQP-0831
IQP-1187
Copyright © 2006, ImQuest Life Sciences. Site Map | Search | Privacy Policy | Terms & Conditions. Site by Synapse Communications.